IDH1 and neoplasm: Using the mutant IDH1 as synthetic long peptide vaccine, Schumacher et al. observed reduced tumor growth in vaccinated mice carrying tumors with the IDH1 point mutation compared to mice carrying IDH1 WT tumors (Table 1) (24).